secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2026-03-31T23:59:59+00:00
Accession:  0001437749-26-010506
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key reports FY2025 revenue $6.1M, net loss $4.6M; Q1'26 revenue up 37% YoY
------------------------------------------------------------------------------

- FY2025 revenue $6.1M, down 12% YoY; net loss $4.6M ($0.69/sh) vs $4.3M ($2.09/sh) in 2024.
- Preliminary Q1'26 revenue $2.2M, up 37% YoY and 80% vs Q4'25; expects break-even in 2026.
- Cash $2.7M at year-end, up from $0.4M; book value $7.6M vs $3.8M.
- Defense sector revenue over trailing 12 months exceeded $2.2M; new partnerships in India, Vietnam, Middle East, Nordics.
- Operating expenses reduced 7% to $669K; SG&A down 11%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774926010506/0001437749-26-010506-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774926010506/bkyi20260331_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-010506

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer